Narcolepsy - 25 Studies Found
| Completed |
: Narcolepsy - New Potential Treatment : Narcolepsy : 2014-02-11 :
|
| Completed |
: Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness : Narcolepsy : 2005-09-14 : Drug: Modafinil maximum dosage 400 mg/day (4 tablets) |
| Completed |
: PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome :
: 2005-04-08 : Drug: Modafinil |
| Enrolling by invitation |
: "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" :
: 2015-01-15 : Drug: JZP-110 |
| ACTIVE_NOT_RECRUITING |
: A Study of TAK-861 in Participants With Narcolepsy Type 1 : Narcolepsy Type 1 : 2025-08-03 : TAK-861 tablets |
| Completed |
: A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions : Narcolepsy Type 1 : 2025-08-03 : TAK-861 tablets |
| ACTIVE_NOT_RECRUITING |
: A Study of TAK-861 in Participants With Narcolepsy Type 2 : Narcolepsy Type 2 : 2025-08-03 : TAK-861 tablets. |
| Completed |
: A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy : Narcolepsy : 2025-08-03 : 0.5 g/ml calcium, magnesium, potassium, and sodium oxybates oral solution |
| ACTIVE_NOT_RECRUITING |
: Narcolepsy Nightmare Study : Narcolepsy : 2025-08-03 : Therapy to reduce nightmares, delivered via videoconference sessions |
| COMPLETED |
: A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy : Narcolepsy : 2025-08-03 : 0.5 g/ml calcium, magnesium, potassium, and sodium oxybates oral solution |